4th Quarter - Report

RETIRESAFE for RETIRESAFE

Firm
Client
Income
—
Expenses
$125,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

discussed issues concerning overall healthcare related areas such as Medicare Part B and D

LobbyistCovered position, as disclosed
MARK GIBBONS —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Worked within the Protect Medicare Part D working group to protect and improve Medicare Part D. Continued our support of 340B reform including our support of HR 4710, the Pause Act, which would improve oversight and increase program accountability. In January RetireSafe commented on the Proposed Rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses released in the Federal Register on November 30, 2018. We proposed that the only meaningful change would be one that lowered the patients out-ot-pocket costs. Sent a letter to the Administration concerning some of the proposed changes to Medicare, especially Part D, that we felt threatened the access and safety of older Americans. talked about importance of vaccinations and accessibility. discussed our stance against drug importation.

LobbyistCovered position, as disclosed
MARK GIBBONS New —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4710 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.